Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$228,037
-$1,925,305 QoQ
Shares Held
9,470
-87.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,351
of 2,821 holders
Holding Since
Mar 2021
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jump Financial, LLC holds $60,679,237 across 7 Drug Manufacturers - General names. PFE ranks #6 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,924 | $37,091,175 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
88,471 | $11,177,425 | |
| 3 | NVO |
Novo Nordisk A S
|
123,187 | $5,905,584 | |
| 4 | JNJ |
Johnson & Johnson
|
14,450 | $3,669,866 | |
| 5 | ABBV |
AbbVie Inc.
|
9,600 | $2,415,743 | |
| 6 | PFE |
Pfizer Inc
This page
|
9,470 | $228,037 | |
| 7 | AMRN |
Amarin Corp Plc\Uk
|
12,008 | $191,407 |
All Filings in PFE
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $228,037 | 9,470 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,153,342 | 76,686 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $930,885 | 37,385 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,505,448 | 98,330 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $31,952,168 | 1,260,938 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $8,258,444 | 311,287 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $22,829,636 | 788,861 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,713,263 | 204,191 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $9,500,072 | 342,345 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,488,964 | 155,921 | Shares | Sole | 2024-10-21 | |
| 2023-09-30 | $258,195 | 7,784 | Shares | Sole | 2024-10-21 | |
| 2023-06-30 | $1,371,024 | 37,378 | Shares | Sole | 2024-10-21 | |
| 2023-03-31 | $1,007,760 | 24,700 | Shares | Sole | 2024-10-21 | |
| 2022-12-31 | $259,069 | 5,056 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $1,242,945 | 24,009 | Shares | Sole | 2022-05-12 | |
| 2021-09-30 | $1,931,578 | 44,910 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $516,458 | 14,255 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||